Lumicitabine, CAS 1445385-02-3 Sole GMP Manufacturer
Lumicitabine, CAS 1445385-02-3 stable novel crystalline or amorphous form both we have, Lumicitabine, CAS 1445385-02-3no any IP problem. Lumicitabine, CAS 1445385-02-3 DMF filling, free sample of Lumicitabine, CAS 1445385-02-3.
EOS Med Chem have already carried out Lumicitabine, CAS 1445385-02-3 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lumicitabine, CAS 1445385-02-3 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Lumicitabine, CAS 1445385-02-3 Intermeidates list, most from GMP plant:
Lumicitabine, CAS 1445385-02-3 HNMR, MASS, COA, MSDS we have.
Lumicitabine, CAS 1445385-02-3, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Lumicitabine, CAS 1445385-02-3 stable novel crystalline or amorphous form both we have, Lumicitabine, CAS 1445385-02-3no any IP problem. Lumicitabine, CAS 1445385-02-3 DMF filling, free sample of Lumicitabine, CAS 1445385-02-3.
EOS Med Chem have already carried out Lumicitabine, CAS 1445385-02-3 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lumicitabine, CAS 1445385-02-3 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Lumicitabine, CAS 1445385-02-3 Intermeidates list, most from GMP plant:
| Lumicitabine 1445385-02-3, CAS 1445385-02-3 Intermediate, 784-71-4, stock 8.4kg, assay 98.4%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-59-8, stock 1.2kg, assay 98.4%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-61-2, stock 3.6kg, assay 98.5%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445387-00-7, stock 2.9kg, assay 98.7%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-64-5, stock 9.7kg, assay 98.1%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-88-3, stock 7.9kg, assay 98.3%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-90-7, stock 2.8kg, assay 98.7%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445393-75-8, stock 5.2kg, assay 98.2%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1983951-30-9, stock 8kg, assay 98.2%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1904619-34-6, stock 6.1kg, assay 98.9%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1904619-35-7, stock 4.4kg, assay 99%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1904619-36-8, stock 6.4kg, assay 98.1%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445379-94-1, stock 6.3kg, assay 98.3%, White powder. |
| Lumicitabine, CAS 1445385-02-3 Intermediate, 1445388-91-9, stock 3.8kg, assay 98.2%, White powder. |
Lumicitabine, CAS 1445385-02-3 HNMR, MASS, COA, MSDS we have.
Lumicitabine, CAS 1445385-02-3, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
